文献速递胸部肿瘤

肺癌筛查的获益与挑战:数据综述及实施纲要

Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.
PubMed 文献 · J Thorac Oncol · 2020-11-12

本文综述了肺癌筛查(CTLS)在高危人群中可早期发现肺癌并降低肺癌相关死亡率,但全球高危人群接受筛查者不足5%。文章分析了低参与率的原因(医生对辐射、假阳性、过度诊断和成本的担忧)并提供了筛查项目实施的关键要素和更新版共享决策辅助工具。

要点

  • 年度CTLS在高危人群中可早期检出肺癌并降低肺癌相关死亡率。
  • 全球高危人群中接受CTLS者不足5%,主要因多国实施延迟。
  • 医生对辐射暴露、假阳性、过度诊断和成本的担忧是低参与率因素。

核心结论

  • 年度CTLS在高危个体中可早期发现肺癌并降低肺癌相关死亡率。
  • 全球高危人群CTLS接受率不足5%,需推动项目实施与优化。

研究设计与样本

  • 文献综述,评估CTLS的潜在风险与获益,并综述筛查项目关键要素及更新版共享决策辅助工具。

主要发现

  • 肺癌是全球癌症相关死亡首位原因,约占所有癌症相关死亡的近五分之一。
  • 全球高危人群中接受CTLS者不足5%。
  • 在美国等长期推荐CTLS的国家,低参与率与患者和医生对推荐缺乏认知以及医生对辐射暴露、假阳性、过度诊断和成本的担忧有关。

关键数值与推荐

  • 美国预防服务工作组等多家医学组织推荐高危人群每年进行CTLS。

临床怎么用

  • 综述筛查项目关键要素和更新版共享决策辅助工具,为项目开发和优化提供指导。
  • 综述评估「高危」人群的研究,可能影响美国及其他考虑实施肺癌筛查国家的未来指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for almost a fifth of all cancer-related deaths. Annual computed tomographic lung cancer screening (CTLS) detects lung cancer at earlier stages and reduces lung cancer-related mortality among high-risk individuals. Many medical organizations, including the U.S. Preventive Services Task Force, recommend annual CTLS in high-risk populations. However, fewer than 5% of individuals worldwide at high risk for lung cancer have undergone screening. In large part, this is owing to delayed implementation of CTLS in many countries throughout the world. Factors contributing to low uptake in countries with longstanding CTLS endorsement, such as the United States, include lack of patient and clinician awareness of current recommendations in favor of CTLS and clinician concerns about CTLS-related radiation exposure, false-positive results, overdiagnosis, and cost. This review of the literature serves to address these concerns by evaluating the potential risks and benefits of CTLS. Review of key components of a lung screening program, along with an updated shared decision aid, provides guidance for program development and optimization. Review of studies evaluating the population considered "high-risk" is included as this may affect future guidelines within the United States and other countries considering lung screening implementation.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Sands J, Tammemägi MC, Couraud S, et al. Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation. J Thorac Oncol. 2020. PMID: 33188913. doi:10.1016/j.jtho.2020.10.127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。